Shared decision-making about autologous stem cell transplantation: A qualitative study of older patients and physicians.

Qian Liu, Jianfang Li, Lixiu Wang, Chuyue Shan, Li Wang, Dan Ye, Dan Luo, Huijing Zou, Bing Xiang Yang, Xiao Qin Wang, Jingjing Zhang, Fuling Zhou
{"title":"Shared decision-making about autologous stem cell transplantation: A qualitative study of older patients and physicians.","authors":"Qian Liu, Jianfang Li, Lixiu Wang, Chuyue Shan, Li Wang, Dan Ye, Dan Luo, Huijing Zou, Bing Xiang Yang, Xiao Qin Wang, Jingjing Zhang, Fuling Zhou","doi":"10.1111/jgs.19276","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The decision-making process between autologous hematopoietic stem cell transplant (autoHSCT) and less-intensive treatments necessitates shared decision-making between older patients with hematological malignancies and healthcare providers. However, there is limited knowledge from both perspectives. This qualitative study aimed to comprehensively understand the experiences of shared decision-making regarding autoHSCT among older patients with hematological malignancies and physicians.</p><p><strong>Methods: </strong>Older patients and physicians were recruited from the hematology department at one of the affiliated general hospitals of Wuhan University. They participated in semi-structured, in-depth face-to-face individual interviews from August 2022 to March 2023. The interviews explored their experiences with shared decision-making about autoHSCT. Interviews were transcribed verbatim and analyzed using Colaizzi's phenomenological method.</p><p><strong>Results: </strong>Thirteen older patients and eight physicians were recruited. Two themes were identified: (1) Factors influencing AutoHSCT recommendations and decision-making: Seven factors were categorized into three groups: physician-driven factors (pretransplant assessments, experience-based judgment, and communication approaches), patient-driven factors (perceived benefits and risks, financial challenges, and family involvement), and mutual trust between patients and physicians, which is a bidirectional factor relying on both physicians' trust and the active participation of patients in the decision-making process. (2) Treatment planning and outcome expectations: Regardless of treatment choices, patients focused on engaging in self-management and prioritizing quality of life, and maintaining hope for positive outcomes.</p><p><strong>Conclusions: </strong>The shared decision-making process for autoHSCT between older patients with hematological malignancies and physicians is shaped by physician-driven factors, patient-driven factors, and mutual trust. These findings provide a foundation for developing patient-centered care strategies, including decision aids and enhanced communication training for physicians, aimed at improving outcomes for older patients facing complex treatment choices. Future research should explore how these factors interact over time, through longitudinal studies, to assess their long-term impact on patient outcomes and quality of life.</p>","PeriodicalId":94112,"journal":{"name":"Journal of the American Geriatrics Society","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Geriatrics Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/jgs.19276","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The decision-making process between autologous hematopoietic stem cell transplant (autoHSCT) and less-intensive treatments necessitates shared decision-making between older patients with hematological malignancies and healthcare providers. However, there is limited knowledge from both perspectives. This qualitative study aimed to comprehensively understand the experiences of shared decision-making regarding autoHSCT among older patients with hematological malignancies and physicians.

Methods: Older patients and physicians were recruited from the hematology department at one of the affiliated general hospitals of Wuhan University. They participated in semi-structured, in-depth face-to-face individual interviews from August 2022 to March 2023. The interviews explored their experiences with shared decision-making about autoHSCT. Interviews were transcribed verbatim and analyzed using Colaizzi's phenomenological method.

Results: Thirteen older patients and eight physicians were recruited. Two themes were identified: (1) Factors influencing AutoHSCT recommendations and decision-making: Seven factors were categorized into three groups: physician-driven factors (pretransplant assessments, experience-based judgment, and communication approaches), patient-driven factors (perceived benefits and risks, financial challenges, and family involvement), and mutual trust between patients and physicians, which is a bidirectional factor relying on both physicians' trust and the active participation of patients in the decision-making process. (2) Treatment planning and outcome expectations: Regardless of treatment choices, patients focused on engaging in self-management and prioritizing quality of life, and maintaining hope for positive outcomes.

Conclusions: The shared decision-making process for autoHSCT between older patients with hematological malignancies and physicians is shaped by physician-driven factors, patient-driven factors, and mutual trust. These findings provide a foundation for developing patient-centered care strategies, including decision aids and enhanced communication training for physicians, aimed at improving outcomes for older patients facing complex treatment choices. Future research should explore how these factors interact over time, through longitudinal studies, to assess their long-term impact on patient outcomes and quality of life.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
自体干细胞移植的共同决策:一项针对老年患者和医生的定性研究。
背景:在自体造血干细胞移植(autologous hematopoietic stem cell transplant,autoHSCT)和低强度治疗之间的决策过程,需要老年血液恶性肿瘤患者和医疗服务提供者共同决策。然而,从这两个角度获得的知识都很有限。这项定性研究旨在全面了解老年血液恶性肿瘤患者和医生在共同决策自体HSCT方面的经验:方法:从武汉大学附属某综合医院血液科招募老年患者和医生。他们在 2022 年 8 月至 2023 年 3 月期间参加了半结构化、面对面的深入访谈。访谈探讨了他们对自体肝细胞移植共同决策的经验。访谈内容逐字记录,并采用科莱兹现象学方法进行分析:共招募了 13 名老年患者和 8 名医生。确定了两个主题:(1) 影响 AutoHSCT 建议和决策的因素:七个因素被分为三组:医生驱动因素(移植前评估、基于经验的判断和沟通方法)、患者驱动因素(感知到的益处和风险、经济挑战和家庭参与)以及患者和医生之间的相互信任,这是一个双向因素,既依赖于医生的信任,也依赖于患者在决策过程中的积极参与。(2) 治疗计划和结果预期:无论选择哪种治疗方法,患者都注重参与自我管理和优先考虑生活质量,并对积极的治疗结果保持希望:老年血液恶性肿瘤患者与医生之间的自体血细胞移植共同决策过程受医生驱动因素、患者驱动因素和相互信任的影响。这些发现为制定以患者为中心的护理策略奠定了基础,包括决策辅助工具和加强医生沟通培训,旨在改善面临复杂治疗选择的老年患者的治疗效果。未来的研究应通过纵向研究探讨这些因素如何随着时间的推移而相互作用,以评估它们对患者治疗效果和生活质量的长期影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊介绍:
期刊最新文献
Innovation in delirium care: A standardized intervention to reverse inattention using touch and movement. Accelerating the pace of elder justice policy to meet the needs of a growing aging population. Age Self Care, a program to improve aging in place through group learning and incremental behavior change: Preliminary data. Beyond usability: Designing digital health interventions for implementation with older adults. Defining key deprescribing measures from electronic health data: A multisite data harmonization project.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1